Show simple item record

dc.contributor.authorMayowa, Owaladi
dc.contributor.authorKumuthini, Judith
dc.contributor.authorOsman, Sankoh
dc.date.accessioned2024-08-16T10:28:25Z
dc.date.available2024-08-16T10:28:25Z
dc.date.issued2023
dc.identifier.urihttps://doi.org/10.1016/S2214-109X(23)00303-0
dc.identifier.urihttp://hdl.handle.net/10566/9444
dc.description.abstractHealth is pivotal to human development. Nevertheless, progress towards achieving improved health worldwide has been slow, especially in Africa.1, 2 Accelerated progress is only possible with synergistic partnerships, one model of which involves four stakeholders: academia, policy makers, industry, and civil society—the so-called quadruple helix.3, 4 Academia (ie, higher-education institutions and research organisations) provides novel theories and ideas and conducts rigorous research, resulting in new understanding and solutions.5 Industry (eg, pharmaceutical, medical equipment manufacturing, and information-technology companies) leads entrepreneurship, product development, scaling up solutions, and population-wide commercialisation. Policy makers (ie, governments and multilateral agencies) work to improve, promote, and protect the health and wealth of populations by providing political, legal or legislative, ethical, anthropological, and socioeconomic regulatory frameworks for an egalitarian society, with inclusive and sustainable development for all.en_US
dc.language.isoenen_US
dc.publisherElsevier Ltden_US
dc.subjectEpidemiologicalen_US
dc.subjectAfrican Biobanken_US
dc.subjectDementia Consortiumen_US
dc.subjectSustainable developmenten_US
dc.subjectStakeholdersen_US
dc.titleMaximising human health and development through synergistic partnerships: the African Biobank and Longitudinal Epidemiological Ecosystemen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record